Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 751 AL 765

Occurrence of β-N-methylamino-l-alanine (BMAA) and Isomers in Aquatic Environments and Aquatic Food Sources for Humans

Lance E, Arnich N, Maignien T, Biré R.

Toxins (Basel). 2018 Feb 14;10(2):83. doi: 10.3390/toxins10020083.

Deep Brain Stimulation for Parkinson Disease Does not Worsen or Improve Postural Instability: A Prospective Cohort Trial

Brandmeir NJ, Brandmeir CL, Carr D, Kuzma K, McInerney J.

Neurosurgery. 2018 Dec 1;83(6):1173-1182. doi: 10.1093/neuros/nyx602.

Approaching adaptive control in neurostimulation for Parkinson disease: Autopilot on

Weiss D, Massano J.

Neurology. 2018 Mar 13;90(11):497-498. doi: 10.1212/WNL.0000000000005111. Epub 2018 Feb 14.

Relevance of sleep quality on caregiver burden in Parkinson's disease

Bartolomei L, Pastore A, Meligrana L, Sanson E, Bonetto N, Minicuci GM, Marsala SZ, Mesiano T, Bragagnolo L, Antonini A.

Neurol Sci. 2018 May;39(5):835-839. doi: 10.1007/s10072-018-3252-2. Epub 2018 Feb 14.

The potential role of herbal products in the treatment of Parkinson's disease

Amro MS, Teoh SL, Norzana AG, Srijit D.

Clin Ter. 2018 Jan-Feb;169(1):e23-e33. doi: 10.7417/T.2018.2050.

Gait & Posture Special Issue: Gait adaptations in response to obstacle type in fallers with Parkinson's disease

Alcock L, Galna B, Hausdorff JM, Lord S, Rochester L.

Gait Posture. 2018 Mar;61:368-374. doi: 10.1016/j.gaitpost.2018.01.030. Epub 2018 Jan 31.

Endemic atypical parkinsonism

Silveira-Moriyama L, Lees AJ.

J Neurol Sci. 2018 May 15;388:220-221. doi: 10.1016/j.jns.2018.02.018. Epub 2018 Feb 7.

Sleep disorders and Parkinson disease; lessons from genetics

Gan-Or Z, Alcalay RN, Rouleau GA, Postuma RB.

Sleep Med Rev. 2018 Oct;41:101-112. doi: 10.1016/j.smrv.2018.01.006. Epub 2018 Jan 31.

Access to the CNS: Biomarker Strategies for Dopaminergic Treatments

van den Brink WJ, Palic S, Köhler I, de Lange ECM.

Pharm Res. 2018 Feb 15;35(3):64. doi: 10.1007/s11095-017-2333-x.

Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases

Navarro-Mabarak C, Camacho-Carranza R, Espinosa-Aguirre JJ.

Drug Metab Rev. 2018 May;50(2):95-108. doi: 10.1080/03602532.2018.1439502. Epub 2018 Feb 16.

Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome

van Horne CG, Quintero JE, Slevin JT, Anderson-Mooney A, Gurwell JA, Welleford AS, Lamm JR, Wagner RP, Gerhardt GA.

J Neurosurg. 2018 Dec 1;129(6):1550-1561. doi: 10.3171/2017.8.JNS163222. Epub 2018 Feb 18.

The plasma membrane calcium pumps-The old and the new

Zaidi A, Adewale M, McLean L, Ramlow P.

Neurosci Lett. 2018 Jan 10;663:12-17. doi: 10.1016/j.neulet.2017.09.066.

The role of Plasma Membrane Calcium ATPases (PMCAs) in neurodegenerative disorders

Hajieva P, Baeken MW, Moosmann B.

Neurosci Lett. 2018 Jan 10;663:29-38. doi: 10.1016/j.neulet.2017.09.033.

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study

Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S; ADP Investigators.

Lancet Neurol. 2018 Mar;17(3):213-222. doi: 10.1016/S1474-4422(18)30039-5.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias